What is the treatment of psoriatic arthritis?

Hello,

Welcome to icliniq.com.

I went through your query.

Skyrizi (Risankizumab) is a relatively new medication that has been approved by the FDA (The United States Food and Drug Administration) for the treatment of psoriasis and psoriatic arthritis. It is a biological drug that targets a specific protein called interleukin-23 (IL-23), which is involved in the inflammatory process that causes both skin and joint symptoms in people with psoriasis and psoriasis arthritis.

Skyrizi is effective in reducing both skin lesions and joint symptoms in people with moderate to severe psoriasis and psoriatic arthritis who have not responded well to other treatments. It is typically given as two subcutaneous injections (under the skin) every 12 weeks after an initial loading dose.

There could be several reasons why your doctor may not have prescribed Skyrizi. One possibility is that your doctor may have determined that another medication would be more appropriate for your specific case based on factors such as your medical history, symptoms, and response to previous treatments. Another possibility is that your insurance may not cover Skyrizi or may require prior authorization before it can be prescribed, which could make it less convenient or more expensive for you.

It is always a good idea to discuss any concerns or questions you have about your treatment plan with your doctor, as they can provide personalized guidance based on your circumstances. They can also help you weigh the potential benefits and risks of different medications, as well as any potential side effects or interactions with other medications you may be taking.

Hope it helps.

Thanks and regards.